Jyong Biotech Ltd.
MENSNasdaqHealthcare · Pharmaceutical Preparations · E9 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Signs
● 1 severe● 0 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 20-Fmissed a reporting deadline ↗Apr 29, 2026
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 241,009 | 4.3 | +23.9% |
| Apr 30, 2026 | 194,489 | 2.4 | +46.2% |
| Apr 15, 2026 | 133,023 | 1.0 | -43.2% |
| Mar 31, 2026 | 234,254 | 1.2 | -18.9% |
| Mar 13, 2026 | 288,865 | 1.4 | -22.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗- 20-FANNUAL REPORTMay 15, 2026
- NT 20-FNOTIFICATION OF LATE FILINGApr 29, 2026
- SCHEDULE 13DApr 24, 2026
- 3PRIMARY DOCUMENTApr 14, 2026
- 3PRIMARY DOCUMENTApr 8, 2026
- 3PRIMARY DOCUMENTApr 1, 2026
- 3PRIMARY DOCUMENTApr 1, 2026
- 3PRIMARY DOCUMENTApr 1, 2026
- 3PRIMARY DOCUMENTApr 1, 2026
- 3PRIMARY DOCUMENTApr 1, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERFeb 6, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERJan 9, 2026
- SP 15D2Jun 30, 2025
- 6-KREPORT OF FOREIGN PRIVATE ISSUERJun 20, 2025
- 424B4PROSPECTUSJun 18, 2025
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.